This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for the addition of a cold oxygen plasma treatment step to the current manufacturing process for the boston equalens (itafluorofocon a), boston equalens ii, and boston orthokeratology (oprifocon a) shaping lens
Device | RIGID GAS PERMEABLE CONTACT LENSES (BOSTON ORTHOKERATOLOGY) |
Classification Name | Lens, Contact, Orthokeratology, Overnight |
Generic Name | Lens, Contact, Orthokeratology, Overnight |
Applicant | BAUSCH & LOMB |
Date Received | 2006-01-27 |
Decision Date | 2006-05-30 |
PMA | P010062 |
Supplement | S004 |
Product Code | NUU |
Advisory Committee | Ophthalmic |
Supplement Type | 135 Review Track For 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | BAUSCH & LOMB 1400 North Goodman St. rochester, NY 14603-0450 |
Supplement Number | Date | Supplement Type |
---|---|---|
P010062 | Original Filing | |
S011 | 2018-05-25 | Real-time Process |
S010 | 2016-06-27 | 30-day Notice |
S009 | 2011-05-31 | 30-day Notice |
S008 | 2010-10-20 | Normal 180 Day Track No User Fee |
S007 | 2009-10-13 | Normal 180 Day Track No User Fee |
S006 | 2008-01-31 | Real-time Process |
S005 | 2006-12-21 | Real-time Process |
S004 | 2006-01-27 | 135 Review Track For 30-day Notice |
S003 | 2005-04-18 | Normal 180 Day Track No User Fee |
S002 | 2004-09-01 | Real-time Process |
S001 | 2004-07-06 | Real-time Process |